KLAC vs PROF · P/E 55, rev $12.16B vs rev $10.7M
KLA Corporation (KLAC) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported KLAC revenue for 2025-06-30 was $12.16B. Net income was $4.06B. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
KLAC currently screens at market cap $252.01B and trailing P/E 54.7. PROF currently screens at market cap $238.7M.
Not investment advice. Open the KLAC and PROF stock pages for the full models.
Not investment advice.